Patrick C. Gedeon

Also affiliated with Dana-Farber Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach”.

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000213

N/A

0DataRank · unranked

27 citations

David J. Snyder, Ivan Spasojević, Patrick C. Gedeon, Luis Sánchez-Pérez, John H. Sampson +1 more

GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody

PLoS ONE(2020)10.1371/journal.pone.0236374

N/A

0DataRank · unranked

7 citations

Michael A. Streicker, Teilo Schaller, Gary E. Archer, Micheal P. Jokinen, John H. Sampson +1 more

Targeting STING to generate therapeutic anti-tumor immunity

Cancer Cell(2025)10.1016/j.ccell.2025.12.002

N/A

0DataRank · unranked

16 citations

Anthony F. Cordova, Patrick C. Gedeon, David A. Barbie, Caroline G. Fahey